Global Parenteral Nutrition Market Insights, Trends, Driving Factors, Focus Points, Potential Markets, Developments, Company Share Analysis, and Forecast 2023 – 2033
Parenteral Nutrition: Product Overview
Global Parenteral Nutrition Market was valued at USD 5593.9 million in 2023 and is reach to USD 10102.0 Million by 2033 at a CAGR of 6.08
Parenteral nutrition is another way of feeding nutritional products such as proteins, carbohydrates, fats, minerals, vitamins, etc. while the individual is unable to intake required nutrition orally. Parenteral nutrition can be taken by infants, youngsters, and adults as well. In addition, individuals who are suffering from irritable bowel syndrome (IBS), constipation or other stomach-related diseases and disorders, and are unable to eat or digest food can adopt parenteral nutrition to maintain nutrition prominence of the body. Parenteral nutrition is a sterilized liquid natural formula given directly through the veins with the help of an intravenous tube.
Dynamics: Driving and Hampering Elements
Increasing prevalence of malnutrition children, especially in developing and under-developed countries across the globe, coupled with need for parenteral nutrition to properly balance minerals, vitamins, lipids, amino acids, etc. are some of the major factors expected to drive demand for parenteral nutrition and drive market growth.
According to the UNICEF, imbalanced nutrition value in the infants in the initial post-birth 1,000 days could lead to impaired cognitive ability and stunted growth. In addition, rising number of cesarean section deliveries and premature births, and undernourished mothers giving birth to weak children are other major factors expected to drive growth of the target market significantly. For instance, as per the National Center for Healthcare Statistics, as of 2016, birth rate of premature children in the US was approximately 9.6%.
Moreover, patients suffering from various chronic diseases such as cancer and heart-related diseases need high nutritional content in order to fight against the disease and maintain hydration, and energy levels of the body. This is another key factor expected to fuel growth of the target market. In 2014 for instance, as per a report published by the World Health Organization (WHO), nearly 14 Bn cases of mortality were registered due to cancer. In addition, WHO stated that by 2025 this number is expected to increase by 70% in terms of cancer diagnosis.
Growing geriatric population and rising prevalence of chronic illnesses associated with age factor are leading to higher demand for parenteral nutrition, thus supporting market growth. Various benefits offered by parenteral nutrition such as simple to follow, better in terms of efficient nutrients, motivates stomach blood flow, prevents from bacteria, maintains muscle catabolism, etc. at cost-effective prices are factors expected to drive growth of the global parenteral nutrition market.
Increasing number of initiatives by government and healthcare organizations to spread awareness regarding requirement and importance of balanced nutritional value of the body and investments by government to provide nutritional supplements for malnourished children is another prominent factor driving growth of the market.
Among the type segments, the single dose amino acid solutions segment is expected to hold dominant position in terms of revenue share in the target market. The parenteral lipid emulsion segment is expected to register significant growth rate and account for considerable revenue share in the years to come.
By End User:
Among the end user segments, the hospital segment is estimated to account for significant revenue share in the global market.
The market in North America is expected to account for significant share in terms of revenue in the target market and is expected to register X.X% compound annual growth rate over the 10-year forecast period, owing to increasing innovation in parenteral nutrition by the government and favorable compensation policies in countries in the region.
The market in the Europe market is expected to account for substantial revenue share in the target market, owing to increasing adoption of parenteral nutrition for Cancer patients, and by individuals with stomach-related disorders and lifestyle-related diseases in countries in the region.
Global Parenteral Nutrition Market Segmentation:
Market Segmentation, by Nutrition Type
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
Market Segmentation, By End User
Market Segmentation, by Region
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size USD 5593.9 million Growth Rate 6.08% Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2023-2033 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Braun Melsungen AG
- Fresenius Kabi AG
- Allergan plc
- Grifols International S.A
- Hospira Inc.
- Otsuka Pharmaceutical Factory Inc.
- Baxter International, Inc.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Vifor Pharma
- Aculife Healthcare
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!